CA3098414C - Composition pharmaceutique comprenant du salbutamol - Google Patents
Composition pharmaceutique comprenant du salbutamolInfo
- Publication number
- CA3098414C CA3098414C CA3098414A CA3098414A CA3098414C CA 3098414 C CA3098414 C CA 3098414C CA 3098414 A CA3098414 A CA 3098414A CA 3098414 A CA3098414 A CA 3098414A CA 3098414 C CA3098414 C CA 3098414C
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- weight
- salbutamol
- total weight
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
La présente invention concerne une composition pharmaceutique. La composition comprend : (i) un composant médicamenteux comprenant du salbutamol; et (ii) un composant propulseur comprenant du 1,1-difluoroéthane (HFA -152a).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1807053.2A GB2573297A (en) | 2018-04-30 | 2018-04-30 | Pharmaceutical composition |
| GB1807053.2 | 2018-04-30 | ||
| PCT/GB2019/051136 WO2019211578A1 (fr) | 2018-04-30 | 2019-04-23 | Composition pharmaceutique comprenant du salbutamol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3098414A1 CA3098414A1 (fr) | 2019-11-07 |
| CA3098414C true CA3098414C (fr) | 2024-10-08 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021205045C1 (en) | Pharmaceutical composition | |
| US11883372B2 (en) | Pharmaceutical composition | |
| AU2019264005B2 (en) | Pharmaceutical composition comprising salbutamol | |
| CA3098414C (fr) | Composition pharmaceutique comprenant du salbutamol | |
| WO2022029403A1 (fr) | Composition pharmaceutique | |
| GB2597755A (en) | Pharmaceutical composition | |
| NZ752430B2 (en) | Pharmaceutical composition |